Cargando…

A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial

BACKGROUND: Effective topical treatment options for patients with primary axillary hyperhidrosis (PAHH) are limited. A phase I trial showed promising results regarding the efficacy and safety of a topical cream containing glycopyrronium bromide (GPB). OBJECTIVES: To assess the efficacy, safety and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abels, C., Soeberdt, M., Kilic, A., Reich, H., Knie, U., Jourdan, C., Schramm, K., Heimstaedt‐Muskett, S., Masur, C., Szeimies, R.‐M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451866/ https://www.ncbi.nlm.nih.gov/pubmed/33445205 http://dx.doi.org/10.1111/bjd.19810

Ejemplares similares

Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis
por: Pariser, David M., et al.
Publicado: (2021)

Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its Use
por: Lamb, Yvette N.
Publicado: (2019)

Correction to: Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its Use
por: Lamb, Yvette N.
Publicado: (2019)

Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis: A randomized, double‐blind, vehicle‐controlled study
por: Yokozeki, Hiroo, et al.
Publicado: (2021)

A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis
por: Glaser, Dee Anna, et al.
Publicado: (2019)

Efficacy of hydrophilic or lipophilic emulsions containing Echinacea purpurea extract in treatment of different types of pruritus
por: Kilic, Ana, et al.
Publicado: (2018)

Skin acidification with a water‐in‐oil emulsion (pH 4) restores disrupted epidermal barrier and improves structure of lipid lamellae in the elderly
por: Kilic, Ana, et al.
Publicado: (2019)

Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials
por: Pariser, David M., et al.
Publicado: (2018)

Two‐week prospective observational study of 5% sofpironium bromide gel in Japanese patients with primary axillary hyperhidrosis
por: Fujimoto, Tomoko, et al.
Publicado: (2022)

Bronchodilator efficacy of extrafine glycopyrronium bromide: the Glyco 2 study
por: Singh, Dave, et al.
Publicado: (2017)

Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials
por: Hebert, Adelaide A., et al.
Publicado: (2018)

Long‐term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44‐week open‐label extension study
por: Hebert, Adelaide A., et al.
Publicado: (2020)

Effects of Direct Current Administration on Hyperhidrosis Disease Severity Scale in Patients with Axillary Hyperhidrosis
por: Şener, Serpil, et al.
Publicado: (2019)

Cost‐of‐illness study for axillary hyperhidrosis in Japan
por: Murota, Hiroyuki, et al.
Publicado: (2021)

Topical treatment of vaginal dryness with a non-hormonal cream in women undergoing breast cancer treatment - An open prospective multicenter study
por: Chatsiproios, Dimitrios, et al.
Publicado: (2019)

Role of once-daily glycopyrronium bromide (NVA237) in the management of COPD
por: D’Urzo, Anthony
Publicado: (2013)

Single incision thoracoscopic sympathectomy for palmar and axillary hyperhidrosis
por: Baram, Aram
Publicado: (2014)

A novel model-based approach for dose determination of glycopyrronium bromide in COPD
por: Arievich, Helen, et al.
Publicado: (2012)

Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in Japan
por: Horita, Nobuyuki, et al.
Publicado: (2015)

Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide
por: Mantero, Marco, et al.
Publicado: (2018)

Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide
por: Ridolo, Erminia, et al.
Publicado: (2019)

Effectiveness of glycopyrronium bromide in the treatment of small airway dysfunction: A retrospective study
por: Petrone, Albino, et al.
Publicado: (2022)

Clinical Evaluation of a Microwave Device for Treating Axillary Hyperhidrosis
por: Hong, H Chih-Ho, et al.
Publicado: (2012)

Surgical treatment of axillary hyperhidrosis by suction-curettage of sweat glands
por: de Rezende, Rebeca Maffra, et al.
Publicado: (2014)

Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma
por: Chapman, Kenneth R., et al.
Publicado: (2021)

Questionnaire-based epidemiological survey of primary focal hyperhidrosis and survey on current medical management of primary axillary hyperhidrosis in Japan
por: Fujimoto, Tomoko, et al.
Publicado: (2022)

Impact of microwave thermolysis energy levels on patient‐reported outcomes for axillary hyperhidrosis and osmidrosis
por: Grove, G. L., et al.
Publicado: (2022)

Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD
por: Prakash, Anoop, et al.
Publicado: (2015)

A case report of QT prolongation with glycopyrronium bromide in a patient with chronic tamoxifen use
por: Chiu, Michael H., et al.
Publicado: (2016)

Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodine
por: Mohan, V., et al.
Publicado: (2021)

Pharmacokinetics of extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide in adolescent and adult patients with asthma
por: Kuna, Piotr, et al.
Publicado: (2022)

Comparison of the efficacy of ETS with different segments for palmar, axillary and plantar hyperhidrosis
por: Hong, Ziqiang, et al.
Publicado: (2023)

Hyperhidrosis quality of life index (HidroQoL): further validation by applying classical test theory and item response theory using data from a phase III clinical trial
por: Donhauser, Theresa, et al.
Publicado: (2023)

Aquagenic palmoplantar keratoderma therapeutic response to topical glycopyrronium
por: Medhus, Emily J., et al.
Publicado: (2021)

A novel option for treatment of primary axillary hyperhidrosis: Fractionated microneedle radiofrequency
por: Naeini, F Fatemi, et al.
Publicado: (2015)

A phase III, 52‐week, open‐label study to evaluate the safety and efficacy of 5% sofpironium bromide (BBI‐4000) gel in Japanese patients with primary axillary hyperhidrosis
por: Fujimoto, Tomoko, et al.
Publicado: (2021)

A retrospective cohort study of T3 versus T4 thoracoscopic sympathectomy for primary palmar hyperhidrosis and primary palmar hyperhidrosis with axillary and plantar sweating
por: Xie, Hongya, et al.
Publicado: (2019)

Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide
por: Singh, Dave, et al.
Publicado: (2017)

A phase 3, multicenter, randomized, double‐blind, vehicle‐controlled, parallel‐group study of 5% sofpironium bromide (BBI‐4000) gel in Japanese patients with primary axillary hyperhidrosis
por: Yokozeki, Hiroo, et al.
Publicado: (2021)

The Effect of Thoracoscopic Sympathicotomy at the Fourth Rib (R4) for the Treatment of Palmar and Axillary Hyperhidrosis
por: Kim, Jae-Bum, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_e86vnn3l9sb8ed43gpja9oeqkn